| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.19B | +15.7% |
| Cost of Revenue | $105.7M | +35.4% |
| R&D Expense | $294.5M | +11.0% |
| SG&A Expense | $164.1M | +20.8% |
| Operating Income | $58.4M | +85.2% |
| Pre-tax Income | $66.8M | +98.0% |
| Income Tax | $30.4M | +611.2% |
| Net Income | $36.3M | -8.4% |
| EPS (Basic) | $0.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $306.4M | -36.1% |
| Short-term Investments | $94.2M | — |
| Accounts Receivable | $131.9M | +22.9% |
| Current Assets | $596.0M | -7.6% |
| Total Assets | $1.02B | -3.3% |
| Current Liabilities | $182.8M | +11.5% |
| Total Liabilities | $305.6M | +2.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $192.3M | -9.6% |
| Capital Expenditures | $32.0M | +13.1% |
| Investing Cash Flow | -$126.1M | -356.2% |
| Financing Cash Flow | -$237.5M | +21.0% |
| Free Cash Flow | $160.3M | -13.0% |
| -3.8% |
| EPS (Diluted) | $0.50 | +0.0% |
| Stockholders' Equity |
| $710.3M |
| -5.5% |